Guruprasad R. Pattar, Ph.D. - Publications

Affiliations: 
2014 Cellular and Integrative Physiology Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Physiology Biology, Cell Biology, Molecular Biology

6/10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Bhonagiri P, Pattar GR, Habegger KM, McCarthy AM, Tackett L, Elmendorf JS. Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance. Endocrinology. 152: 3373-84. PMID 21712361 DOI: 10.1210/En.2011-1295  0.792
2010 Bhonagiri P, Pattar GR, Horvath EM, Habegger KM, McCarthy AM, Elmendorf JS. Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin (Endocrinology (2009) 150, (1636-1645) DOI: 10.1210/en.2008-1102) Endocrinology. 151: 2967. DOI: 10.1210/En.2010-0489  0.766
2009 Bhonagiri P, Pattar GR, Horvath EM, Habegger KM, McCarthy AM, Elmendorf JS. Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin. Endocrinology. 150: 1636-45. PMID 19036880 DOI: 10.1210/En.2008-1102  0.793
2006 Pattar GR, Tackett L, Liu P, Elmendorf JS. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutation Research. 610: 93-100. PMID 16870493 DOI: 10.1016/J.Mrgentox.2006.06.018  0.742
2006 Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Molecular Endocrinology (Baltimore, Md.). 20: 857-70. PMID 16339278 DOI: 10.1210/Me.2005-0255  0.707
2004 Chen G, Raman P, Bhonagiri P, Strawbridge AB, Pattar GR, Elmendorf JS. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. The Journal of Biological Chemistry. 279: 39705-9. PMID 15277534 DOI: 10.1074/Jbc.C400171200  0.727
Low-probability matches (unlikely to be authored by this person)
2020 Jerkins GW, Pattar GR, Kannarr SR. A Review of Topical Cyclosporine A Formulations-A Disease-Modifying Agent for Keratoconjunctivitis Sicca. Clinical Ophthalmology (Auckland, N.Z.). 14: 481-489. PMID 32109984 DOI: 10.2147/Opth.S228070  0.213
2019 Pattar GR, Jerkins G, Evans DG, Torkildsen GL, Ousle GW, Hollander DA, Holdbrook M, Senchyna M. Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface. PMID 31542368 DOI: 10.1016/J.Jtos.2019.09.006  0.183
2014 Arthur SN, Cantor LB, WuDunn D, Pattar GR, Catoira-Boyle Y, Morgan LS, Hoop JS. Efficacy, safety, and survival rates of IOP-lowering effect of phacoemulsification alone or combined with canaloplasty in glaucoma patients. Journal of Glaucoma. 23: 316-20. PMID 23377581 DOI: 10.1097/Ijg.0B013E3182741Ca9  0.182
2022 Torkildsen GL, Pattar GR, Jerkins G, Striffler K, Nau J. Efficacy and Safety of Single-Dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial. Clinical Therapeutics. PMID 35965109 DOI: 10.1016/j.clinthera.2022.07.006  0.027
Hide low-probability matches.